{"transactions":[{"id":2336142,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-14T20:36:28.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":139387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":139386,"derivative":{"underlying":"Common Stock","underlying_shares":139387},"source":{"system":"sec-edgar","filing":"0001055726-22-000020","document":"wf-form4_164728997772803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000020/wf-form4_164728997772803.xml","form_type":"4"}},{"id":2336141,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-14T20:36:28.000Z","date":"2022-03-11","kind":"tax_withholding","acquired":false,"shares":39698,"price":3.22,"value":127827.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":1422627,"source":{"system":"sec-edgar","filing":"0001055726-22-000020","document":"wf-form4_164728997772803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000020/wf-form4_164728997772803.xml","form_type":"4"}},{"id":2336140,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-14T20:36:28.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":139387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":1462325,"source":{"system":"sec-edgar","filing":"0001055726-22-000020","document":"wf-form4_164728997772803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000020/wf-form4_164728997772803.xml","form_type":"4"}},{"id":2342477,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-09T21:07:49.000Z","date":"2022-03-08","kind":"exercise","acquired":false,"shares":63700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":63700},"source":{"system":"sec-edgar","filing":"0001055726-22-000016","document":"wf-form4_164686005009477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000016/wf-form4_164686005009477.xml","form_type":"4"}},{"id":2342476,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-09T21:07:49.000Z","date":"2022-03-08","kind":"tax_withholding","acquired":false,"shares":18142,"price":3.26,"value":59142.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":1322938,"source":{"system":"sec-edgar","filing":"0001055726-22-000016","document":"wf-form4_164686005009477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000016/wf-form4_164686005009477.xml","form_type":"4"}},{"id":2342475,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-09T21:07:49.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":63700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":1341080,"source":{"system":"sec-edgar","filing":"0001055726-22-000016","document":"wf-form4_164686005009477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000016/wf-form4_164686005009477.xml","form_type":"4"}},{"id":2366325,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:38:58.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":468500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":468500,"derivative":{"underlying":"Common Stock","underlying_shares":468500},"source":{"system":"sec-edgar","filing":"0001055726-22-000009","document":"wf-form4_164617791888639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000009/wf-form4_164617791888639.xml","form_type":"4"}},{"id":2366324,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2022-03-01T23:38:58.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":627700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting schedule for the 627,700 options is as follows: 156,925 shares vested on February 26, 2022; 156,925 shares will vest on February 26, 2023; 156,925 shares will vest on February 26, 2024; 156,925 shares will vest on February 26, 2025."}],"balance_after":627700,"derivative":{"exercise_price":3.22,"exercise_date":"2022-02-26","expiration_date":"2032-02-26","underlying":"Common Stock","underlying_shares":627700},"source":{"system":"sec-edgar","filing":"0001055726-22-000009","document":"wf-form4_164617791888639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000009/wf-form4_164617791888639.xml","form_type":"4"}},{"id":2366323,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:38:58.000Z","date":"2022-02-26","kind":"exercise","acquired":false,"shares":68767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":137533,"derivative":{"underlying":"Common Stock","underlying_shares":68767},"source":{"system":"sec-edgar","filing":"0001055726-22-000009","document":"wf-form4_164617791888639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000009/wf-form4_164617791888639.xml","form_type":"4"}},{"id":2366322,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-01T23:38:58.000Z","date":"2022-02-26","kind":"tax_withholding","acquired":false,"shares":20045,"price":3.22,"value":64544.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":1277380,"source":{"system":"sec-edgar","filing":"0001055726-22-000009","document":"wf-form4_164617791888639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000009/wf-form4_164617791888639.xml","form_type":"4"}},{"id":2366321,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-01T23:38:58.000Z","date":"2022-02-26","kind":"exercise","acquired":true,"shares":68767,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":1297425,"source":{"system":"sec-edgar","filing":"0001055726-22-000009","document":"wf-form4_164617791888639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000009/wf-form4_164617791888639.xml","form_type":"4"}},{"id":2792717,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-12T23:33:30.000Z","date":"2021-03-11","kind":"exercise","acquired":false,"shares":139387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares will vest on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares will vest on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares will vest on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares will vest on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":278773,"derivative":{"underlying":"Common Stock","underlying_shares":139387},"source":{"system":"sec-edgar","filing":"0001055726-21-000024","document":"wf-form4_161559198968115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000024/wf-form4_161559198968115.xml","form_type":"4"}},{"id":2792716,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-12T23:33:30.000Z","date":"2021-03-11","kind":"tax_withholding","acquired":false,"shares":74545,"price":10.57,"value":787940.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":1228658,"source":{"system":"sec-edgar","filing":"0001055726-21-000024","document":"wf-form4_161559198968115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000024/wf-form4_161559198968115.xml","form_type":"4"}},{"id":2792715,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-12T23:33:30.000Z","date":"2021-03-11","kind":"exercise","acquired":true,"shares":139387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares will vest on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":1303203,"source":{"system":"sec-edgar","filing":"0001055726-21-000024","document":"wf-form4_161559198968115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000024/wf-form4_161559198968115.xml","form_type":"4"}},{"id":2800873,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-10T00:05:43.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":63700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":63700,"derivative":{"underlying":"Common Stock","underlying_shares":63700},"source":{"system":"sec-edgar","filing":"0001055726-21-000022","document":"wf-form4_161533472915714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000022/wf-form4_161533472915714.xml","form_type":"4"}},{"id":2800872,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-10T00:05:43.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":120100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares vested on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares vested on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares vested on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares vested on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":120100},"source":{"system":"sec-edgar","filing":"0001055726-21-000022","document":"wf-form4_161533472915714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000022/wf-form4_161533472915714.xml","form_type":"4"}},{"id":2800871,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-10T00:05:43.000Z","date":"2021-03-08","kind":"tax_withholding","acquired":false,"shares":34067,"price":8.91,"value":303536.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":1163816,"source":{"system":"sec-edgar","filing":"0001055726-21-000022","document":"wf-form4_161533472915714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000022/wf-form4_161533472915714.xml","form_type":"4"}},{"id":2800870,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-10T00:05:43.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":63700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":1197883,"source":{"system":"sec-edgar","filing":"0001055726-21-000022","document":"wf-form4_161533472915714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000022/wf-form4_161533472915714.xml","form_type":"4"}},{"id":2800869,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-10T00:05:43.000Z","date":"2021-03-05","kind":"tax_withholding","acquired":false,"shares":64230,"price":9.19,"value":590273.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":1134183,"source":{"system":"sec-edgar","filing":"0001055726-21-000022","document":"wf-form4_161533472915714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000022/wf-form4_161533472915714.xml","form_type":"4"}},{"id":2800868,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-10T00:05:43.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":120100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares vested on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":1198413,"source":{"system":"sec-edgar","filing":"0001055726-21-000022","document":"wf-form4_161533472915714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000022/wf-form4_161533472915714.xml","form_type":"4"}},{"id":2830317,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-27T00:08:04.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":206300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares will vest on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares will vest on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares will vest on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":206300,"derivative":{"underlying":"Common Stock","underlying_shares":206300},"source":{"system":"sec-edgar","filing":"0001055726-21-000013","document":"wf-form4_161438445356817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000013/wf-form4_161438445356817.xml","form_type":"4"}},{"id":2830316,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2021-02-27T00:08:04.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":319800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 319,800 options is as follows: 79,950 shares vested on February 26, 2021; 79,950 shares will vest on February 26, 2022; 79,950 shares will vest on February 26, 2023; 79,950 shares will vest on February 26, 2024."}],"balance_after":319800,"derivative":{"exercise_price":11.1,"exercise_date":"2021-02-26","expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":319800},"source":{"system":"sec-edgar","filing":"0001055726-21-000013","document":"wf-form4_161438445356817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000013/wf-form4_161438445356817.xml","form_type":"4"}},{"id":2882717,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2021-02-04T00:14:08.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"shares","element":"transactionShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."}],"balance_after":0,"derivative":{"exercise_price":4.56,"exercise_date":"2011-03-11","expiration_date":"2021-03-11","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001055726-21-000008","document":"wf-form4_161239761257738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000008/wf-form4_161239761257738.xml","form_type":"4"}},{"id":2882716,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-04T00:14:08.000Z","date":"2021-02-03","kind":"sale","acquired":false,"shares":62500,"price":14.24,"value":890000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $13.81 to $14.64, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1078313,"source":{"system":"sec-edgar","filing":"0001055726-21-000008","document":"wf-form4_161239761257738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000008/wf-form4_161239761257738.xml","form_type":"4"}},{"id":2882715,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-04T00:14:08.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":62500,"price":4.56,"value":285000.0,"ownership":{"direct":true},"balance_after":1140813,"source":{"system":"sec-edgar","filing":"0001055726-21-000008","document":"wf-form4_161239761257738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000008/wf-form4_161239761257738.xml","form_type":"4"}},{"id":2882714,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-04T00:14:08.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":100000,"price":15,"value":1500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":1078313,"source":{"system":"sec-edgar","filing":"0001055726-21-000008","document":"wf-form4_161239761257738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000008/wf-form4_161239761257738.xml","form_type":"4"}},{"id":2927958,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-31T21:02:41.000Z","date":"2020-12-29","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction represents a charitable donation. This is not a market transaction, thus no price has been reported."}],"balance_after":1178313,"source":{"system":"sec-edgar","filing":"0001055726-20-000057","document":"wf-form4_160944854960637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000057/wf-form4_160944854960637.xml","form_type":"4"}},{"id":3072722,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-31T23:12:22.000Z","date":"2020-07-30","kind":"sale","acquired":false,"shares":100000,"price":21.1345,"value":2113450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $20.19 to $22.78, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1188313,"source":{"system":"sec-edgar","filing":"0001055726-20-000045","document":"wf-form4_159623712675309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000045/wf-form4_159623712675309.xml","form_type":"4"}},{"id":3213982,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-12T20:46:27.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":418160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares will vest on March 11, 2021; 139,387 shares will vest on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares will vest on March 11, 2021; 139,387 shares will vest on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares will vest on March 11, 2021; 139,387 shares will vest on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":418160,"derivative":{"underlying":"Common Stock","underlying_shares":418160},"source":{"system":"sec-edgar","filing":"0001055726-20-000017","document":"wf-form4_158404596759720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/wf-form4_158404596759720.xml","form_type":"4"}},{"id":3213981,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-12T20:46:27.000Z","date":"2020-03-10","kind":"exercise","acquired":false,"shares":105700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":105700},"source":{"system":"sec-edgar","filing":"0001055726-20-000017","document":"wf-form4_158404596759720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/wf-form4_158404596759720.xml","form_type":"4"}},{"id":3213980,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-12T20:46:27.000Z","date":"2020-03-10","kind":"tax_withholding","acquired":false,"shares":36826,"price":5.7,"value":209908.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":1288313,"source":{"system":"sec-edgar","filing":"0001055726-20-000017","document":"wf-form4_158404596759720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/wf-form4_158404596759720.xml","form_type":"4"}},{"id":3213979,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-12T20:46:27.000Z","date":"2020-03-10","kind":"exercise","acquired":true,"shares":105700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":1325139,"source":{"system":"sec-edgar","filing":"0001055726-20-000017","document":"wf-form4_158404596759720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/wf-form4_158404596759720.xml","form_type":"4"}},{"id":3221037,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-09T20:18:20.000Z","date":"2020-03-08","kind":"exercise","acquired":false,"shares":63700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares will vest on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares will vest on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares will vest on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares will vest on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":127400,"derivative":{"underlying":"Common Stock","underlying_shares":63700},"source":{"system":"sec-edgar","filing":"0001055726-20-000008","document":"wf-form4_158378508254040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/wf-form4_158378508254040.xml","form_type":"4"}},{"id":3221036,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-09T20:18:20.000Z","date":"2020-03-05","kind":"exercise","acquired":false,"shares":120100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":120100,"derivative":{"underlying":"Common Stock","underlying_shares":120100},"source":{"system":"sec-edgar","filing":"0001055726-20-000008","document":"wf-form4_158378508254040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/wf-form4_158378508254040.xml","form_type":"4"}},{"id":3221035,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-09T20:18:20.000Z","date":"2020-03-08","kind":"tax_withholding","acquired":false,"shares":27697,"price":14.09,"value":390250.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":1219439,"source":{"system":"sec-edgar","filing":"0001055726-20-000008","document":"wf-form4_158378508254040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/wf-form4_158378508254040.xml","form_type":"4"}},{"id":3221034,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-09T20:18:20.000Z","date":"2020-03-08","kind":"exercise","acquired":true,"shares":63700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares will vest on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":1247136,"source":{"system":"sec-edgar","filing":"0001055726-20-000008","document":"wf-form4_158378508254040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/wf-form4_158378508254040.xml","form_type":"4"}},{"id":3221033,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-09T20:18:20.000Z","date":"2020-03-05","kind":"tax_withholding","acquired":false,"shares":37371,"price":9.8,"value":366235.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":1183436,"source":{"system":"sec-edgar","filing":"0001055726-20-000008","document":"wf-form4_158378508254040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/wf-form4_158378508254040.xml","form_type":"4"}},{"id":3221032,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-09T20:18:20.000Z","date":"2020-03-05","kind":"exercise","acquired":true,"shares":120100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares vested on March 5, 2020; 120,100 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":1220807,"source":{"system":"sec-edgar","filing":"0001055726-20-000008","document":"wf-form4_158378508254040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/wf-form4_158378508254040.xml","form_type":"4"}},{"id":3312732,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-13T17:10:23.000Z","date":"2020-01-13","kind":"purchase","acquired":true,"shares":22500,"price":3.11,"value":69975.0,"ownership":{"direct":true},"balance_after":1100707,"source":{"system":"sec-edgar","filing":"0001055726-20-000002","document":"wf-form4_157893540555654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000002/wf-form4_157893540555654.xml","form_type":"4"}},{"id":3502909,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-06-04T13:00:22.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":296705,"price":2.3078,"value":684735.799,"ownership":{"direct":false,"nature":"By Family Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made by a broker, without instruction by the reporting person, to satisfy a margin call by the broker, to whom these shares were pledged as collateral for a margin loan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These transactions were executed in multiple trades at prices ranging from $2.17 to $2.42, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":816527,"source":{"system":"sec-edgar","filing":"0001055726-19-000046","document":"wf-form4_155965320820052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/wf-form4_155965320820052.xml","form_type":"4"}},{"id":3502908,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-06-04T13:00:22.000Z","date":"2019-05-31","kind":"sale","acquired":false,"shares":500000,"price":2.4016,"value":1200800.0,"ownership":{"direct":false,"nature":"By Family Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made by a broker, without instruction by the reporting person, to satisfy a margin call by the broker, to whom these shares were pledged as collateral for a margin loan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $2.36 to $2.76, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1113232,"source":{"system":"sec-edgar","filing":"0001055726-19-000046","document":"wf-form4_155965320820052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/wf-form4_155965320820052.xml","form_type":"4"}},{"id":3502907,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-06-04T13:00:22.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":832848,"price":2.2987,"value":1914467.6976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made by a broker, without instruction by the reporting person, to satisfy a margin call by the broker, to whom these shares were pledged as collateral for a margin loan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These transactions were executed in multiple trades at prices ranging from $2.15 to $2.41, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1078207,"source":{"system":"sec-edgar","filing":"0001055726-19-000046","document":"wf-form4_155965320820052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/wf-form4_155965320820052.xml","form_type":"4"}},{"id":3502906,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-06-04T13:00:22.000Z","date":"2019-05-31","kind":"sale","acquired":false,"shares":500000,"price":2.4353,"value":1217650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made by a broker, without instruction by the reporting person, to satisfy a margin call by the broker, to whom these shares were pledged as collateral for a margin loan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $2.36 to $2.76, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1911055,"source":{"system":"sec-edgar","filing":"0001055726-19-000046","document":"wf-form4_155965320820052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/wf-form4_155965320820052.xml","form_type":"4"}},{"id":3513886,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-23T20:21:35.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":100000,"price":3.31,"value":331000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made by a broker, without instruction by the reporting person, to satisfy a margin call by the broker, to whom these shares were pledged as collateral for a margin loan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $3.30 to $3.33, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":2411055,"source":{"system":"sec-edgar","filing":"0001055726-19-000044","document":"wf-form4_155864288064924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000044/wf-form4_155864288064924.xml","form_type":"4"}},{"id":3521825,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-17T20:44:41.000Z","date":"2019-05-16","kind":"sale","acquired":false,"shares":61212,"price":3.5,"value":214242.0,"ownership":{"direct":false,"nature":"By Family Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $[3.50] to $[3.53], inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1613232,"source":{"system":"sec-edgar","filing":"0001055726-19-000042","document":"wf-form4_155812586719176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/wf-form4_155812586719176.xml","form_type":"4"}},{"id":3521824,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-17T20:44:41.000Z","date":"2019-05-15","kind":"sale","acquired":false,"shares":75556,"price":3.5,"value":264446.0,"ownership":{"direct":false,"nature":"By Family Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $[3.50] to $[3.53], inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1674444,"source":{"system":"sec-edgar","filing":"0001055726-19-000042","document":"wf-form4_155812586719176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/wf-form4_155812586719176.xml","form_type":"4"}},{"id":3599978,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T21:08:18.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":191100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares will vest on March 8, 2020; 63,700 shares will vest on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares will vest on March 8, 2020; 63,700 shares will vest on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares will vest on March 8, 2020; 63,700 shares will vest on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":191100,"derivative":{"underlying":"Common Stock","underlying_shares":191100},"source":{"system":"sec-edgar","filing":"0001055726-19-000015","document":"wf-form4_155242488364573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/wf-form4_155242488364573.xml","form_type":"4"}},{"id":3599977,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2019-03-12T21:08:18.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":298100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting schedule for the 298,100 options is as follows: 74,525 shares vested on March 8, 2019; 74,525 shares will vest on March 8, 2020; 74,525 shares will vest on March 8, 2021; 74,525 shares will vest on March 8, 2022."}],"balance_after":298100,"derivative":{"exercise_price":3.34,"exercise_date":"2019-03-08","expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":298100},"source":{"system":"sec-edgar","filing":"0001055726-19-000015","document":"wf-form4_155242488364573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/wf-form4_155242488364573.xml","form_type":"4"}},{"id":3599976,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T21:08:18.000Z","date":"2019-03-10","kind":"exercise","acquired":false,"shares":105700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":105700,"derivative":{"underlying":"Common Stock","underlying_shares":105700},"source":{"system":"sec-edgar","filing":"0001055726-19-000015","document":"wf-form4_155242488364573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/wf-form4_155242488364573.xml","form_type":"4"}},{"id":3599975,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T21:08:18.000Z","date":"2019-03-09","kind":"exercise","acquired":false,"shares":57333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units was as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares vested on March 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units was as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares vested on March 9, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units was as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares vested on March 9, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units was as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares vested on March 9, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":57333},"source":{"system":"sec-edgar","filing":"0001055726-19-000015","document":"wf-form4_155242488364573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/wf-form4_155242488364573.xml","form_type":"4"}},{"id":3599974,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-12T21:08:18.000Z","date":"2019-03-10","kind":"tax_withholding","acquired":false,"shares":30104,"price":3.34,"value":100547.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units award reported in footnote (3) herein."}],"balance_after":2511055,"source":{"system":"sec-edgar","filing":"0001055726-19-000015","document":"wf-form4_155242488364573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/wf-form4_155242488364573.xml","form_type":"4"}},{"id":3599973,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-12T21:08:18.000Z","date":"2019-03-10","kind":"exercise","acquired":true,"shares":105700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":2541159,"source":{"system":"sec-edgar","filing":"0001055726-19-000015","document":"wf-form4_155242488364573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/wf-form4_155242488364573.xml","form_type":"4"}},{"id":3599972,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-12T21:08:18.000Z","date":"2019-03-09","kind":"tax_withholding","acquired":false,"shares":16329,"price":3.34,"value":54538.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units award reported in footnote (1) herein."}],"balance_after":2435459,"source":{"system":"sec-edgar","filing":"0001055726-19-000015","document":"wf-form4_155242488364573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/wf-form4_155242488364573.xml","form_type":"4"}},{"id":3599971,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-12T21:08:18.000Z","date":"2019-03-09","kind":"exercise","acquired":true,"shares":57333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units was as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares vested on March 9, 2019."}],"balance_after":2451788,"source":{"system":"sec-edgar","filing":"0001055726-19-000015","document":"wf-form4_155242488364573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/wf-form4_155242488364573.xml","form_type":"4"}},{"id":3606748,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-03-07T22:09:53.000Z","date":"2019-03-05","kind":"exercise","acquired":false,"shares":120100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares will vest on March 5, 2020; 120,100 shares will vest on March 5, 2021.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares will vest on March 5, 2020; 120,100 shares will vest on March 5, 2021.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares will vest on March 5, 2020; 120,100 shares will vest on March 5, 2021.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares will vest on March 5, 2020; 120,100 shares will vest on March 5, 2021.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":240200,"derivative":{"underlying":"Common Stock","underlying_shares":120100},"source":{"system":"sec-edgar","filing":"0001055726-19-000007","document":"wf-form4_155199657903918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000007/wf-form4_155199657903918.xml","form_type":"4"}},{"id":3606747,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-07T22:09:53.000Z","date":"2019-03-05","kind":"tax_withholding","acquired":false,"shares":34139,"price":3.61,"value":123241.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4."}],"balance_after":2394455,"source":{"system":"sec-edgar","filing":"0001055726-19-000007","document":"wf-form4_155199657903918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000007/wf-form4_155199657903918.xml","form_type":"4"}},{"id":3606746,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-07T22:09:53.000Z","date":"2019-03-05","kind":"exercise","acquired":true,"shares":120100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares vested on March 5, 2019; 120,100 shares will vest on March 5, 2020; 120,100 shares will vest on March 5, 2021.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":2428594,"source":{"system":"sec-edgar","filing":"0001055726-19-000007","document":"wf-form4_155199657903918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000007/wf-form4_155199657903918.xml","form_type":"4"}},{"id":3816036,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2018-09-14T21:12:56.000Z","date":"2018-09-12","kind":"exercise","acquired":false,"shares":49060,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.08,"exercise_date":"2008-09-12","expiration_date":"2018-09-12","underlying":"Common Stock","underlying_shares":49060},"source":{"system":"sec-edgar","filing":"0001055726-18-000042","document":"wf-form4_153695955718652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/wf-form4_153695955718652.xml","form_type":"4"}},{"id":3816035,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-09-14T21:12:56.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":49060,"price":5.37,"value":263452.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $5.32 to $5.44, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":2308494,"source":{"system":"sec-edgar","filing":"0001055726-18-000042","document":"wf-form4_153695955718652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/wf-form4_153695955718652.xml","form_type":"4"}},{"id":3816034,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-09-14T21:12:56.000Z","date":"2018-09-12","kind":"exercise","acquired":true,"shares":49060,"price":5.08,"value":249224.8,"ownership":{"direct":true},"balance_after":2357554,"source":{"system":"sec-edgar","filing":"0001055726-18-000042","document":"wf-form4_153695955718652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/wf-form4_153695955718652.xml","form_type":"4"}},{"id":3941402,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-05-09T22:10:11.000Z","date":"2018-05-08","kind":"exercise","acquired":false,"shares":23333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the original 70,000 restricted stock units granted was as follows:  23,334 shares vested on May 8, 2016; 23,333 shares vested on May 8, 2017; and 23,333 shares vested on May 8, 2018.  Vested units of restricted stock could have been settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the original 70,000 restricted stock units granted was as follows:  23,334 shares vested on May 8, 2016; 23,333 shares vested on May 8, 2017; and 23,333 shares vested on May 8, 2018.  Vested units of restricted stock could have been settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the original 70,000 restricted stock units granted was as follows:  23,334 shares vested on May 8, 2016; 23,333 shares vested on May 8, 2017; and 23,333 shares vested on May 8, 2018.  Vested units of restricted stock could have been settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":23333},"source":{"system":"sec-edgar","filing":"0001055726-18-000027","document":"wf-form4_152590379716247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000027/wf-form4_152590379716247.xml","form_type":"4"}},{"id":3941401,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-09T22:10:11.000Z","date":"2018-05-08","kind":"tax_withholding","acquired":false,"shares":6646,"price":4.68,"value":31103.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":2308494,"source":{"system":"sec-edgar","filing":"0001055726-18-000027","document":"wf-form4_152590379716247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000027/wf-form4_152590379716247.xml","form_type":"4"}},{"id":3941400,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-09T22:10:11.000Z","date":"2018-05-08","kind":"exercise","acquired":true,"shares":23333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the original 70,000 restricted stock units granted was as follows:  23,334 shares vested on May 8, 2016; 23,333 shares vested on May 8, 2017; and 23,333 shares vested on May 8, 2018.  Vested units of restricted stock could have been settled in shares of common stock, cash or a combination of both."}],"balance_after":2315140,"source":{"system":"sec-edgar","filing":"0001055726-18-000027","document":"wf-form4_152590379716247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000027/wf-form4_152590379716247.xml","form_type":"4"}},{"id":3964180,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2018-04-13T22:35:41.000Z","date":"2018-04-13","kind":"exercise","acquired":false,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.16,"exercise_date":"2013-03-14","expiration_date":"2023-03-14","underlying":"Common Stock","underlying_shares":107500},"source":{"system":"sec-edgar","filing":"0001055726-18-000022","document":"wf-form4_152365890387009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/wf-form4_152365890387009.xml","form_type":"4"}},{"id":3964179,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2018-04-13T22:35:41.000Z","date":"2018-04-12","kind":"exercise","acquired":false,"shares":103750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.4,"exercise_date":"2012-02-23","expiration_date":"2022-02-23","underlying":"Common Stock","underlying_shares":103750},"source":{"system":"sec-edgar","filing":"0001055726-18-000022","document":"wf-form4_152365890387009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/wf-form4_152365890387009.xml","form_type":"4"}},{"id":3964178,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-04-13T22:35:41.000Z","date":"2018-04-13","kind":"sale","acquired":false,"shares":107500,"price":5.055,"value":543412.5,"ownership":{"direct":true},"balance_after":2291807,"source":{"system":"sec-edgar","filing":"0001055726-18-000022","document":"wf-form4_152365890387009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/wf-form4_152365890387009.xml","form_type":"4"}},{"id":3964177,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-04-13T22:35:41.000Z","date":"2018-04-13","kind":"exercise","acquired":true,"shares":107500,"price":2.16,"value":232200.0,"ownership":{"direct":true},"balance_after":2399307,"source":{"system":"sec-edgar","filing":"0001055726-18-000022","document":"wf-form4_152365890387009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/wf-form4_152365890387009.xml","form_type":"4"}},{"id":3964176,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-04-13T22:35:41.000Z","date":"2018-04-12","kind":"sale","acquired":false,"shares":103750,"price":5.1387,"value":533140.125,"ownership":{"direct":true},"balance_after":2291807,"source":{"system":"sec-edgar","filing":"0001055726-18-000022","document":"wf-form4_152365890387009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/wf-form4_152365890387009.xml","form_type":"4"}},{"id":3964175,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-04-13T22:35:41.000Z","date":"2018-04-12","kind":"exercise","acquired":true,"shares":103750,"price":2.4,"value":249000.0,"ownership":{"direct":true},"balance_after":2395557,"source":{"system":"sec-edgar","filing":"0001055726-18-000022","document":"wf-form4_152365890387009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/wf-form4_152365890387009.xml","form_type":"4"}},{"id":3998904,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-13T22:34:23.000Z","date":"2018-03-10","kind":"exercise","acquired":false,"shares":105700,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":211400,"derivative":{"underlying":"Common Stock","underlying_shares":105700},"source":{"system":"sec-edgar","filing":"0001055726-18-000008","document":"wf-form4_152098044956325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000008/wf-form4_152098044956325.xml","form_type":"4"}},{"id":3998903,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-13T22:34:23.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":57334,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":57333,"derivative":{"underlying":"Common Stock","underlying_shares":57333},"source":{"system":"sec-edgar","filing":"0001055726-18-000008","document":"wf-form4_152098044956325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000008/wf-form4_152098044956325.xml","form_type":"4"}},{"id":3998902,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:34:23.000Z","date":"2018-03-10","kind":"tax_withholding","acquired":false,"shares":30104,"price":4.51,"value":135769.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":2291807,"source":{"system":"sec-edgar","filing":"0001055726-18-000008","document":"wf-form4_152098044956325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000008/wf-form4_152098044956325.xml","form_type":"4"}},{"id":3998901,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:34:23.000Z","date":"2018-03-10","kind":"exercise","acquired":true,"shares":105700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":2321911,"source":{"system":"sec-edgar","filing":"0001055726-18-000008","document":"wf-form4_152098044956325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000008/wf-form4_152098044956325.xml","form_type":"4"}},{"id":3998900,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:34:23.000Z","date":"2018-03-09","kind":"tax_withholding","acquired":false,"shares":15944,"price":4.51,"value":71907.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":2216211,"source":{"system":"sec-edgar","filing":"0001055726-18-000008","document":"wf-form4_152098044956325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000008/wf-form4_152098044956325.xml","form_type":"4"}},{"id":3998899,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-13T22:34:23.000Z","date":"2018-03-09","kind":"exercise","acquired":true,"shares":57333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":2232155,"source":{"system":"sec-edgar","filing":"0001055726-18-000008","document":"wf-form4_152098044956325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000008/wf-form4_152098044956325.xml","form_type":"4"}},{"id":4008711,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-08T00:41:13.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":360300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares will vest on March 5, 2019; 120,100 shares will vest on March 5, 2020; 120,100 shares will vest on March 5, 2021.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares will vest on March 5, 2019; 120,100 shares will vest on March 5, 2020; 120,100 shares will vest on March 5, 2021.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 360,300 restricted stock units is as follows: 120,100 shares will vest on March 5, 2019; 120,100 shares will vest on March 5, 2020; 120,100 shares will vest on March 5, 2021.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":360300,"derivative":{"underlying":"Common Stock","underlying_shares":360300},"source":{"system":"sec-edgar","filing":"0001055726-18-000002","document":"wf-form4_152046965167200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000002/wf-form4_152046965167200.xml","form_type":"4"}},{"id":4008710,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2018-03-08T00:41:13.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":138250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting schedule for the 138,250 options is as follows: 34,563 shares vested on March 5, 2018; 34,563 shares will vest on March 5, 2019; 34,562 shares will vest on March 5, 2020; 34,562 shares will vest on March 5, 2021."}],"balance_after":138250,"derivative":{"exercise_price":4.29,"exercise_date":"2018-03-05","expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":138250},"source":{"system":"sec-edgar","filing":"0001055726-18-000002","document":"wf-form4_152046965167200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000002/wf-form4_152046965167200.xml","form_type":"4"}},{"id":4008709,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-08T00:41:13.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 40,000 restricted stock units was as follows: 13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 40,000 restricted stock units was as follows: 13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 40,000 restricted stock units was as follows: 13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 40,000 restricted stock units was as follows: 13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001055726-18-000002","document":"wf-form4_152046965167200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000002/wf-form4_152046965167200.xml","form_type":"4"}},{"id":4008708,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-08T00:41:13.000Z","date":"2018-03-05","kind":"tax_withholding","acquired":false,"shares":3711,"price":4.29,"value":15920.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":2174822,"source":{"system":"sec-edgar","filing":"0001055726-18-000002","document":"wf-form4_152046965167200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000002/wf-form4_152046965167200.xml","form_type":"4"}},{"id":4008707,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-08T00:41:13.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 40,000 restricted stock units was as follows: 13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares vested on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":2178533,"source":{"system":"sec-edgar","filing":"0001055726-18-000002","document":"wf-form4_152046965167200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000002/wf-form4_152046965167200.xml","form_type":"4"}},{"id":4247552,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2017-08-01T18:26:37.000Z","date":"2017-07-28","kind":"exercise","acquired":false,"shares":61325,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.08,"exercise_date":"2007-09-28","expiration_date":"2017-09-28","underlying":"Common Stock","underlying_shares":61325},"source":{"system":"sec-edgar","filing":"0001055726-17-000033","document":"wf-form4_150161198347248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000033/wf-form4_150161198347248.xml","form_type":"4"}},{"id":4247551,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-01T18:26:37.000Z","date":"2017-07-28","kind":"exercise","acquired":true,"shares":61325,"price":5.08,"value":311531.0,"ownership":{"direct":true},"balance_after":2165200,"source":{"system":"sec-edgar","filing":"0001055726-17-000033","document":"wf-form4_150161198347248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000033/wf-form4_150161198347248.xml","form_type":"4"}},{"id":4328687,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-05-09T23:44:34.000Z","date":"2017-05-08","kind":"exercise","acquired":false,"shares":23333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 70,000 restricted stock units is as follows: 23,334 shares vested on May 8, 2016; 23,333 shares vested on May 8, 2017; 23,333 shares will vest on May 8, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 70,000 restricted stock units is as follows: 23,334 shares vested on May 8, 2016; 23,333 shares vested on May 8, 2017; 23,333 shares will vest on May 8, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 70,000 restricted stock units is as follows: 23,334 shares vested on May 8, 2016; 23,333 shares vested on May 8, 2017; 23,333 shares will vest on May 8, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 70,000 restricted stock units is as follows: 23,334 shares vested on May 8, 2016; 23,333 shares vested on May 8, 2017; 23,333 shares will vest on May 8, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":23333,"derivative":{"underlying":"Common Stock","underlying_shares":23333},"source":{"system":"sec-edgar","filing":"0001055726-17-000022","document":"wf-form4_149437345893121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000022/wf-form4_149437345893121.xml","form_type":"4"}},{"id":4328686,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-09T23:44:34.000Z","date":"2017-05-08","kind":"tax_withholding","acquired":false,"shares":10755,"price":6.29,"value":67648.95,"ownership":{"direct":true},"balance_after":2103875,"source":{"system":"sec-edgar","filing":"0001055726-17-000022","document":"wf-form4_149437345893121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000022/wf-form4_149437345893121.xml","form_type":"4"}},{"id":4328685,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-09T23:44:34.000Z","date":"2017-05-08","kind":"exercise","acquired":true,"shares":23333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 70,000 restricted stock units is as follows: 23,334 shares vested on May 8, 2016; 23,333 shares vested on May 8, 2017; 23,333 shares will vest on May 8, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":2114630,"source":{"system":"sec-edgar","filing":"0001055726-17-000022","document":"wf-form4_149437345893121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000022/wf-form4_149437345893121.xml","form_type":"4"}},{"id":4365480,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2017-04-03T21:08:59.000Z","date":"2017-03-31","kind":"exercise","acquired":false,"shares":73590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The term of these stock option was extended by 14 days after the expiration of the Company's blackout period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The term of these stock option was extended by 14 days after the expiration of the Company's blackout period."}],"balance_after":0,"derivative":{"exercise_price":5.08,"exercise_date":"2007-01-18","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":73590},"source":{"system":"sec-edgar","filing":"0001055726-17-000020","document":"wf-form4_149125372438902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000020/wf-form4_149125372438902.xml","form_type":"4"}},{"id":4365479,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2017-04-03T21:08:59.000Z","date":"2017-03-30","kind":"exercise","acquired":false,"shares":73590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The term of these stock option was extended by 14 days after the expiration of the Company's blackout period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The term of these stock option was extended by 14 days after the expiration of the Company's blackout period."}],"balance_after":73590,"derivative":{"exercise_price":5.08,"exercise_date":"2007-01-18","expiration_date":"2017-01-18","underlying":"Common Stock","underlying_shares":73590},"source":{"system":"sec-edgar","filing":"0001055726-17-000020","document":"wf-form4_149125372438902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000020/wf-form4_149125372438902.xml","form_type":"4"}},{"id":4365478,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-03T21:08:59.000Z","date":"2017-03-31","kind":"sale","acquired":false,"shares":73590,"price":6.5739,"value":483773.301,"ownership":{"direct":true},"balance_after":2091297,"source":{"system":"sec-edgar","filing":"0001055726-17-000020","document":"wf-form4_149125372438902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000020/wf-form4_149125372438902.xml","form_type":"4"}},{"id":4365477,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-03T21:08:59.000Z","date":"2017-03-31","kind":"exercise","acquired":true,"shares":73590,"price":5.08,"value":373837.2,"ownership":{"direct":true},"balance_after":2164887,"source":{"system":"sec-edgar","filing":"0001055726-17-000020","document":"wf-form4_149125372438902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000020/wf-form4_149125372438902.xml","form_type":"4"}},{"id":4365476,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-03T21:08:59.000Z","date":"2017-03-30","kind":"sale","acquired":false,"shares":73590,"price":6.5051,"value":478710.309,"ownership":{"direct":true},"balance_after":2091297,"source":{"system":"sec-edgar","filing":"0001055726-17-000020","document":"wf-form4_149125372438902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000020/wf-form4_149125372438902.xml","form_type":"4"}},{"id":4365475,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-03T21:08:59.000Z","date":"2017-03-30","kind":"exercise","acquired":true,"shares":73590,"price":5.08,"value":373837.2,"ownership":{"direct":true},"balance_after":2164887,"source":{"system":"sec-edgar","filing":"0001055726-17-000020","document":"wf-form4_149125372438902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000020/wf-form4_149125372438902.xml","form_type":"4"}},{"id":4389232,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-13T21:41:51.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":317100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares will vest on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares will vest on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares will vest on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":317100,"derivative":{"underlying":"Common Stock","underlying_shares":317100},"source":{"system":"sec-edgar","filing":"0001055726-17-000008","document":"wf-form4_148944129682642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000008/wf-form4_148944129682642.xml","form_type":"4"}},{"id":4389231,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2017-03-13T21:41:51.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":43150,"price":6.68,"value":288242.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting schedule for the 43,150 options is as follows: 10,787 shares vested on March 10, 2017; 10,788 shares will vest on March 10, 2018; 10,787 shares will vest on March 10, 2019; 10,788 shares will vest on March 10, 2020."}],"balance_after":43150,"derivative":{"exercise_price":6.68,"exercise_date":"2017-03-10","expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":43150},"source":{"system":"sec-edgar","filing":"0001055726-17-000008","document":"wf-form4_148944129682642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000008/wf-form4_148944129682642.xml","form_type":"4"}},{"id":4389230,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-13T21:41:51.000Z","date":"2017-03-09","kind":"exercise","acquired":false,"shares":57334,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 vested on March 9, 2017; 57,333 shares will vest on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 vested on March 9, 2017; 57,333 shares will vest on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 vested on March 9, 2017; 57,333 shares will vest on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 vested on March 9, 2017; 57,333 shares will vest on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":114666,"derivative":{"underlying":"Common Stock","underlying_shares":57334},"source":{"system":"sec-edgar","filing":"0001055726-17-000008","document":"wf-form4_148944129682642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000008/wf-form4_148944129682642.xml","form_type":"4"}},{"id":4389229,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:41:51.000Z","date":"2017-03-10","kind":"tax_withholding","acquired":false,"shares":52605,"price":6.68,"value":351401.4,"ownership":{"direct":true},"balance_after":2091297,"source":{"system":"sec-edgar","filing":"0001055726-17-000008","document":"wf-form4_148944129682642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000008/wf-form4_148944129682642.xml","form_type":"4"}},{"id":4389228,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:41:51.000Z","date":"2017-03-10","kind":"exercise","acquired":true,"shares":139745,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These restricted stock units vested 100% on the March 10, 2017 grant date."}],"balance_after":2143902,"source":{"system":"sec-edgar","filing":"0001055726-17-000008","document":"wf-form4_148944129682642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000008/wf-form4_148944129682642.xml","form_type":"4"}},{"id":4389227,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:41:51.000Z","date":"2017-03-09","kind":"tax_withholding","acquired":false,"shares":17787,"price":6.61,"value":117572.07,"ownership":{"direct":true},"balance_after":2004157,"source":{"system":"sec-edgar","filing":"0001055726-17-000008","document":"wf-form4_148944129682642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000008/wf-form4_148944129682642.xml","form_type":"4"}},{"id":4389226,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:41:51.000Z","date":"2017-03-09","kind":"exercise","acquired":true,"shares":57334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 vested on March 9, 2017; 57,333 shares will vest on March 9, 2018; 57,333 shares will vest on March 9, 2019.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":2021944,"source":{"system":"sec-edgar","filing":"0001055726-17-000008","document":"wf-form4_148944129682642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000008/wf-form4_148944129682642.xml","form_type":"4"}},{"id":4398307,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-07T21:41:39.000Z","date":"2017-03-05","kind":"exercise","acquired":false,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 40,000 restricted stock units is as follows:  13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares will vest on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 40,000 restricted stock units is as follows:  13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares will vest on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 40,000 restricted stock units is as follows:  13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares will vest on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 40,000 restricted stock units is as follows:  13,334 shares vested on March 5, 2016; 13,333 shares vested on March 5, 2017; 13,333 shares will vest on March 5, 2018.  Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both."}],"balance_after":13333,"derivative":{"underlying":"Common Stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001055726-17-000002","document":"wf-form4_148892288607267.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000002/wf-form4_148892288607267.xml","form_type":"4"}},{"id":4398306,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":129158,"kind":"person","name":"Kim Jong Joseph","position":1,"cik":"0001464549","reported_name":"Kim Jong Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-07T21:41:39.000Z","date":"2017-03-06","kind":"tax_withholding","acquired":false,"shares":4365,"price":6.95,"value":30336.75,"ownership":{"direct":true},"balance_after":1964610,"source":{"system":"sec-edgar","filing":"0001055726-17-000002","document":"wf-form4_148892288607267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000002/wf-form4_148892288607267.xml","form_type":"4"}}],"next_cursor":"2017-03-07T21:41:39.000000Z,4398306"}